Interpretable machine learning for urothelial cells classification and risk scoring in urine cytology.

Journal: iScience
Published Date:

Abstract

Urine cytology is widely used for detecting urothelial carcinoma (UC), though its performance is constrained by limited sensitivity and substantial interobserver variability. An interpretable machine learning framework was developed to classify urothelial cells and to estimate slide-level risk of high-grade UC. 10,230 expert-annotated urothelial cells were used to extract 20 quantitative feature representing cytomorphologic criteria defined by the Paris System. Ordinal logistic regression and random forest models were trained and validated, achieving over 90% accuracy for classifying cells into normal, atypical, or suspicious categories. Interpretable morphological features were identified as major contributors to prediction. Slide-level risk scores were derived from aggregated cell probabilities in a validation set of 247 cases. These scores effectively stratified negative, atypical, low-grade, and high-grade UC cases (p < 0.0001). Through alignment with established cytologic criteria, this feature-based framework provides a transparent and quantitative approach that may improve consistency, efficiency, and interpretability in digital urinary cytology.

Authors

  • Lei Xiong
    Tianjin Branch of China National Offshore Oil Corporation, Tianjin, 300400, China.
  • Xinyi Cao
    Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.
  • Yu Shang
    The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang Province, China.
  • Zongyue Lu
    Department of Medical Development, Hangzhou Zhiwei Information and Technology Co., Ltd., Hangzhou, China.
  • Hao Jiang
    Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , 555 Zuchongzhi Road, Shanghai 201203, China.
  • Chang Shi
  • Chengzhi Zhang
    Department of Information Management, Nanjing University of Science & Technology, Nanjing, China.
  • Zhongjing Ma
    Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Lili Tian
    Philosophy and Social Science Laboratory of Reading and Development in Children and Adolescents, South China Normal University, Ministry of Education, Guangzhou 510631, People's Republic of China. Electronic address: [email protected].
  • Xiaojie Wang
    Beijing University of Posts and Telecommunications, China.
  • Jiwei Liu
    Department of Oncology, The First Hospital of Dalian Medical University (FHDMU), Dalian, China.
  • Jia Li
    Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Tsuihang New District, Guangdong, 528400, PR China; School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.
  • Fengqi Fang
    Department of Oncology, The First Hospital of Dalian Medical University, Dalian, China.

Keywords

No keywords available for this article.